In addition, suggestive effects of glycine on SBP and risk of hypertension were still observed even when all CPS1 variants were removed from the IV, and such findings were in line with another MR study based on six variants for glycine on cardiometabolic diseases when excluding the CPS1 variant [65]. Here, CPS1 is linked to hypertensive disorder.